Global Hematology Partnering Deal Trends, Players and Financials Directory 2019: Deals Signed Between the World's Pharmaceutical and Biotechnology Companies

News provided by

Dec 04, 2019, 16:45 ET

DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The "Global Hematology Partnering 2014-2019: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Hematology Partnering 2014 to 2019 provides the full collection of Hematology disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Hematology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hematology deals.

The report presents financial deal terms values for Hematology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The report includes deals for the following indications: Agranulocytosis, Anemia, Haemolytic, Iron deficiency, Blood substitute, Disseminated intravascular coagulation (DIC), Hemophilia, Immune thrombocytopenic purpura, Neutropenia, Polycythemia, Thalassemia, Thrombocytopenia, Vitamin K Deficiency, Von-Willebrand disease, plus other hematological indications.

Report scope

Trends in Hematology dealmaking in the biopharma industry since 2014
Analysis of Hematology deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Hematology deal contract documents
Comprehensive access to over 200 Hematology deal records
The leading Hematology deals by value since 2014
Most active Hematology dealmakers since 2014

Available deals and contracts are listed by:

Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Hematology dealmaking
2.1. Introduction
2.2. Hematology partnering over the years
2.3. Hematology partnering by deal type
2.4. Hematology partnering by industry sector
2.5. Hematology partnering by stage of development
2.6. Hematology partnering by technology type
2.7. Hematology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Hematology partnering
3.1. Introduction
3.2. Disclosed financials terms for Hematology partnering
3.3. Hematology partnering headline values
3.4. Hematology deal upfront payments
3.5. Hematology deal milestone payments
3.6. Hematology royalty rates

Chapter 4 - Leading Hematology deals and dealmakers
4.1. Introduction
4.2. Most active in Hematology partnering
4.3. List of most active dealmakers in Hematology
4.4. Top Hematology deals by value

Chapter 5 - Hematology contract document directory
5.1. Introduction
5.2. Hematology partnering deals where contract document available

Chapter 6 - Hematology dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Hematology therapeutic target

Appendices

Appendix 1 - Directory of Hematology deals by company A-Z 2014 to 2019
Appendix 2 - Directory of Hematology deals by deal type 2014 to 2019
Appendix 3 - Directory of Hematology deals by stage of development 2014 to 2019
Appendix 4 - Directory of Hematology deals by technology type 2014 to 2019

Companies Mentioned

Abbott Laboratories
Abzena
Accord Healthcare
Accuscience
Acrotech Biopharma
Advanced Biological Laboratories
AffaMed Therapeutics
AkaRx
Akebia Therapeutics
Akers Biosciences
Akron Biotechnology
Alchemia
Alnylam Pharmaceuticals
Alphamedix
American society of Hematology
Amgen
Anthos Therapeutics
Antitope
Apceth
Aplagon
ApoPharma
Aptevo Therapeutics
APT Therapeutics
ArcherDX
Arch Therapeutics
Armaghan Salamat Kish
Armetheon
Arsia Therapeutics
Aruvant Sciences
ASKA Pharmaceuticals
Aspen Holding
AstraZeneca
Audaire Health
AUT Roche Diagnostics Laboratory
AUT University
AVL Sofia
Banc De Sang I Teixits
Baxalta
Baxter International
Bayer
Bayer Healthcare
Baylor College of Medicine
Beijing Leadman Biochemistry
Belgian Red Cross
Bicycle Therapeutics
Bill and Melinda Gates Foundation
Biocept
BIOCORP
bioCSL
Biogen
BioMatrix Specialty Pharmacy
Biomedical Advanced Research and Development Authority
BioMedical Drug Development
BioNano Genomics
Bioverativ
Bleeding Disorders Foundation
Blood Bank Of Delmarva
Blood Centers of America
Blood Systems
Bluebird Bio
BMG Pharmaceuticals
Bonfils Blood Center
Boryung Pharmaceutical
Bristol-Myers Squibb
Bristol-Myers Squibb Foundation
C-Bridge Capital
Cadila Pharmaceuticals
Calbiotech
California Institute for Regenerative Medicine
Calithera Biosciences
Capnia
Cardiome Pharma
Casebia Therapeutics
Case Western Reserve University
Catalyst Biosciences
CEI
Celgene
Central California Blood Center
Cerus
Cesca Therapeutics
Children's Hospital of Philadelphia
Children's Minnesota
China Biologic Products
China Cord Blood
Cincinnati Children's Hospital Medical Center
CJ Corp
Clinigen
CMC Biologics
Comercializadora BioRenal
Cord Blood Registry
Cordlife
CRISPR Therapeutics
CSL Behring
CSL Plasma
Cytonet
CytoSorbents
Daiichi Sankyo
DaVita
Defense Advanced Research Projects Agency
Department of Health and Human Services
Dimension Therapeutics
Dova Pharmaceuticals
Dr. Reddy's Laboratories
Dr Franz Kohler Chemie
Duke University
Eagle Pharmaceuticals
EMD Serono
Emergent BioSolutions
Emirates Gastroenterology & Hepatology Society
EpiDestiny
ERBA Diagnostics
Ergomed
Esperion Therapeutics
European Medicines Agency
Evonik Industries
Evotec
Expression Therapeutics
Fibriant
Fibrogen
Fondazione Telethon
Fortis Healthcare
Fresenius Kabi Pharmaceuticals
Fresenius Medical Care
Gamida Cell
Gateway Hemophilia Association
GC Pharma
GE Healthcare
Gencia Biotech
Genexine
Genoptix
GenTegra
GenVec
Genzyme
Global Blood Disorder Foundation
GNYHA Services
Golden Meditech
Government Scientific Source
Greater New York Hospital Association
Grifols
Haemonetics Corporation
HanAll Pharmaceuticals
Harvard Medical School
Healthcare Royalty Partners
Helsinn Healthcare
HemaCare
Hemophilia Foundation of Southern California
HEMORIO
Henry Schein
Heska
Hologic
Homology Medicines
Horiba
Horizon Pharma plc
Immucor
Immune Deficiency Foundation
Incyte
Inserm
Inserm Transfert
Institute for Genome Statistics and Bioinformatics
Institute of Human Genetics
Instrumentation Laboratory
Intrinsic LifeSciences
inviCRO
Ionis Pharmaceuticals
Irish Haemophilia Society
Israeli Ministry of Industry and Commerce
Israeli National Authority for Technological Innovation
Jazz Pharmaceuticals
Karolinska University Hospital
Kiadis Pharma
Kurin
Kyoto University
LabPro
La Jolla Pharmaceutical
Lee's Pharmaceutical
LFB Biotechnologies
LifeHealth
Ligand Pharmaceuticals
Lonza
Loop Medical
Mallinckrodt Pharmaceuticals
Massachusetts Institute of Technology
Masterlab
Masters Speciality Pharma
Mayo Clinic
Medgenics
Medial
Medica
MedImmune
Meditrade
Medline Industries
Menarini
Merus Labs International
Metabasis Therapeutics
MicroHealth
Miraca Life Sciences
Mitsubishi Tanabe Pharma
Moberg Pharma
National Center for Advancing Translational Sciences (NCATS)
National Heart
Lung and Blood Institute
National Hemophilia Foundation
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
National Transfusiology Center
NCPC GeneTech
New York Blood Center
Novartis
NovImmune
Novo Nordisk
Nxstage Medical
Octapharma
OMRF
OrSense
Ortho-Clinical Diagnostics
Otsuka
Oxford BioMedica
Palex Medical
Pan American Cancer Treatment Centers
PathoQuest
Pathway Diagnostics
PBM Capital Group
Peking University
Pfenex
Pfizer
Pfizer Japan
Pharmacosmos
PhaseBio Pharmaceuticals
Pieris
Portola Pharmaceuticals
Premier Inc
Promethera Biosciences
Prophylix Pharma
Protagonist Therapeutics
Provepharm
Qiagen
Quotient Bioscience
Regen BioPharma
Research Center for Molecular Medicine of the Austrian Academy of Sciences
rEVO Biologics
Rhode Island Blood Center
Rigel Pharmaceuticals
Roche Diagnostics
Rockwell Medical
Roivant Sciences
Romark Laboratories
Royal College of Surgeons (Ireland)
Royalty Pharma
RPRD Diagnostics
Sage Bionetworks
Salix Pharmaceuticals
Samsung Bioepis
Sangamo BioSciences
Sanofi
San Raffaele Telethon Institute for Gene Therapy
Saol Therapeutics
Sayre Therapeutics
SciClone Pharmaceuticals
Science Foundation Ireland
Scil Animal Care
Sekisui Medical
Selecta Biosciences
Selexis
Seventh Sense Biosystems
Shanghai RAAS Blood Products
Shionogi
Shire Laboratories
Shire Pharmaceuticals
Sidero Bioscience
Sigilon Therapeutics
Small Business Innovation Research
Sophia Genetics
Spark Therapeutics
Spectrum Pharmaceuticals
Spindial
SQI Diagnostics
Stanford University
Strides Arcolab
SunCoast Blood Bank (SCBB)
Supernus Pharmaceuticals
Swedish Orphan Biovitrum
Swiss Red Cross
Swiss Transfusion SRC
Sysmex America
Takeda Pharmaceutical
Targacept
Tasly Pharmaceuticals
Tasso
Tennessee Hemophilia
Terumo
Thalassaemia International Federation
The Medicines Company
Thermo Fisher Scientific
TNO Pharma
Tokra Medikal
Topas Therapeutics
Turgut Ilaclari
UCB
Uniformed Services University of the Health Sciences
University College Cork
University of Bonn
University of Maryland Baltimore
University of Pittsburgh
Unyts
US Bioservices
Velesco
Velocity Pharmaceutical Development
Verax Biomedical
Versiti Blood Research Institute
Vertex Pharmaceuticals
Vifor Pharma
Viking Therapeutics
Vitesse Biologics
Wanbang Biopharmaceuticals
Washington University in St Louis
Worcester Polytechnic Institute (WPI)
Xenetic Biosciences

For more information about this report visit https://www.researchandmarkets.com/r/7e86ku

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets